Filing Details

Accession Number:
0000903423-17-000244
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-03-30 16:11:03
Reporting Period:
2017-03-27
Filing Date:
2017-03-30
Accepted Time:
2017-03-30 16:11:03
Original Submission Date:
2017-03-29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1169987 Htg Molecular Diagnostics Inc HTGM Pharmaceutical Preparations (2834) X0
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1131399 Plc Glaxosmithkline 980 Great West Road
Brentford, Middlesex, X0 TW8 9GS
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-03-27 300,000 $10.15 792,781 No 4 S Indirect By S.R. One, Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By S.R. One, Limited
Footnotes
  1. Including 43,538 shares of the Issuer's Common Stock deliverable upon the exercise of a warrant that is exercisable at any time at an exercise price of $14.00.
  2. Shares are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc (Reporting Person).